We use cookies on this site to improve our service, perform analytics, and remember website preferences. By using this site, you consent to these cookies. For more information visit our Privacy Policy

Simplifying T1D management

DailyDose is a diabetes management app designed with the Jacobs Lab at OHSU. It was created to help people with Type 1 Diabetes easily monitor their condition and feel in control of their health.

Client

Artificial Intelligence for Medical Systems (AIMS) Lab & the Harold Schnitzer Diabetes Health Center at OHSU

In Collaboration With

eHealth Innovation at UHN

Funded by

The Leona M. and Harry B. Helmsley Charitable Trust

Services

Environmental Scans, UX/UI Design, Usability Testing

Challenge

Of the 34.2 million Americans living with diabetes, nearly 1.6 million have Type 1 Diabetes (T1D). The complexity of T1D management is burdensome, as it requires people to inject insulin multiple times a day or use an insulin pump, monitor their blood sugar levels, and work hard to maintain a healthy lifestyle and diet. Achieving balance can be difficult, which inspired the Artificial Intelligence for Medical Systems (AIMS) Lab and the Harold Schnitzer Diabetes Health Center at the Oregon Health and Sciences University (OHSU) to develop a technology that could transform the day-to-day experience of those living with the condition — a mobile application known as DailyDose.

Healthcare Human Factors was approached by the teams at OHSU to research the current-state T1D patient experience, reimagining it through the lens of DailyDose. The primary goal of this work was to design a user-centred smartphone application that would simplify T1D management and allow users to feel in control of their health.

Process

DISCOVERY

We began by researching the lived experiences of those with T1D, their needs, and the opportunities that existed for an app that would uniquely and powerfully help them to manage their condition. We conducted user research, which involved an experience scan of a broad group of individuals living with T1D, the formulation of personas and research narratives, and the creation of a formalized value proposition for DailyDose.

The following insights emerged from the experience scan, and served as design probes for the next stage of our process:

What we discovered

unnamed image
T1D is a full-time job

It is something you don’t necessarily want to do, but have to do as a survival imperative.

unnamed image
Not ashamed, but discreet

Many people openly speak about their diabetes with others, but do not publicly announce it. Taking a blood glucose reading or taking their insulin is not a public event.

unnamed image
I’m in control, until I’m not

It’s clear that diabetes has a life of its own sometimes. This can have psychological and social effects.

unnamed image
My disease, my life, my way

While all management strategies include glucose readings and insulin, the interplay of lifestyle, technology, and individual preference impact how individuals manage their T1D.

DESIGN
AND PROTOTYPING

Our research insights guided the design of DailyDose, as we set out to create a seamless user experience.

We were guided by the following design principles:

  • Low Effort – Time in app is low (between 1 – 3 minutes)
  • Does not increase anxiety – Art direction, alerts and notifications are handled delicately when possible
  • Friendly and Trustworthy – Art direction is professional, health data is accurate
  • Personalized – Use is personal. Assigning alerts and curating their experience helps the user to feel in control
  • Support when I need it – Technical support is easy to find and helpful when needed.
Usability Testing

Validating the design on those who have lived experience with T1D was crucial in order to design an app that would truly respond to their needs and experiences. We set up the simulation labs at HHF to resemble the conditions of a home environment and conducted two-hour formative usability evaluations with five participants, each a current pump user who has lived with T1D for over five years.

Outcomes

After final refinements were made, the high fidelity prototype was delivered alongside all visual assets and documentation with specifications for development. The app was then evaluated in a randomized controlled trial which showed that people who followed more of the app’s recommendations saw greater improvements in their glucose management and improved health outcomes. In 2022, we built on the core features of the app based on the data we had gained from the trial while designing a comprehensive clinician dashboard to support a patient-centred model of care.

Read about the next phase of the project